| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019126 |
| Receipt No. | R000022097 |
| Official scientific title of the study | Survey on metformin-induced vitamin B12 deficiency in patients with type 2 diabetes |
| Date of disclosure of the study information | 2015/12/01 |
| Last modified on | 2018/10/02 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Survey on metformin-induced vitamin B12 deficiency in patients with type 2 diabetes | |
| Title of the study (Brief title) | Survey on metformin-induced vitamin B12 deficiency in patients with type 2 diabetes | |
| Region |
|
|
| Condition | ||
| Condition | Type 2 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the reality of metformin-induced vitamin B12 deficiency in patients with type 2 diabetes by measuring the serum vitamin B12 and homocysteine level as the diagnostic index. To investigate the relationship of the dose of metformin and vitamin B12 deficiency. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The corelation between the period of taking metformin and serum homocysteine or vitamin B12 level as the diagnostic index for vitamin B12 deficiency. |
| Key secondary outcomes | 1)The corelation between the daily dose of metformin and serum homocysteine or vitamin B12 level as the diagnostic index for vitamin B12 deficiency.
2)The corelation between the cumulative dose of metformin and serum homocysteine or vitamin B12 level. 3)The relationship between macrocytic anemia and serum homocysteine or vitamin B12 level. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Type 2 diabetes
2)type 2 patients who taking metformin within the conditions specified in the product labeling |
|||
| Key exclusion criteria | 1)Is receiving vitamin B12 preparation including vitamin B12 supplements
2)Is receiving steroids, and gastrectomy (include segmentectomy and total resection, but not endoscopic mucosal resection) 3)Is pregnant, nursing, or planned to become pregnant 4)With malabsorption(chronic pancreatitis,inflammatory bowel disease and malabsorption syndrome) 5)With severe infection, pre or post surgery, and serious trauma,malignancy 6)With renal dysfunction (Serum Creatinine male: >= 1.5 mg/dL, female: >= 1.3 mg/dL) 7)Considered as inadequate by the investigator |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiko Sakaguchi |
| Organization | Kobe University Graduate School of Medicine |
| Division name | Division of Diabetes and Endocrinology |
| Address | 7-5-1 Kusunokichou, Chuo-ku, Kobe, Japan |
| TEL | 078-382-5861 |
| kzhkskgc@med.kobe-u.ac.jp | |
| Public contact | |
| Name of contact person | Yuko Okada |
| Organization | Kobe University Graduate School of Medicine |
| Division name | Division of Diabetes and Endocrinology |
| Address | 7-5-1 Kusunokichou, Chuo-ku, Kobe, Japan |
| TEL | 078-382-5861 |
| Homepage URL | |
| yokada@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Kobe University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 神戸大学大学院医学研究科 糖尿病・内分泌内科(兵庫県)
|
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | cross-sectional study.
Patients who visit our hospital from February 2016 to December 2020 and those who meeting the criteria. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022097 |